Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Indoles"" wg kryterium: Temat


Starter badań:

Tytuł:
Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation.
Autorzy:
Yang F; School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.
Su Y; School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.
Yan C; School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.
Chen T; College of Chemistry and Materials Science, Jinan University, Guangzhou, China.
Cheung PCK; School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 12; Vol. 22 (1), pp. 166. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Microbiome*
Inflammatory Bowel Diseases*/drug therapy
Colitis*/chemically induced
Colitis*/drug therapy
Indoles*
Polymers*
Animals ; Mice ; Saccharomyces cerevisiae ; Reactive Oxygen Species ; Administration, Oral
Czasopismo naukowe
Tytuł:
Aspirin/amoxicillin loaded chitosan microparticles and polydopamine modified titanium implants to combat infections and promote osteogenesis.
Autorzy:
Shi Y; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Lai Y; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Guo Y; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Cai Z; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Mao C; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Lu M; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Ren C; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research Center of Oral Biomaterial & Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Ong JL; Department of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX, 78249, USA. .
Chen W; Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7624. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Amoxicillin*/pharmacology
Chitosan*/pharmacology
Indoles*
Polymers*
Rats ; Animals ; Aspirin/pharmacology ; Titanium/pharmacology ; Osteogenesis ; Staphylococcus aureus ; Escherichia coli ; Anti-Bacterial Agents/pharmacology ; Surface Properties ; Coated Materials, Biocompatible/pharmacology
Czasopismo naukowe
Tytuł:
CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.
Autorzy:
Li H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Feng H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang T; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu J; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen X; Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu L; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia W; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ji X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Cheng X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Zhao R; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 21; Vol. 23 (1), pp. 59. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Indoles*
Quinolines*
Humans ; Animals ; Mice ; RNA, Circular/genetics ; Tumor Suppressor Protein p53 ; Prospective Studies ; Cell Proliferation/genetics ; Biomarkers ; Ubiquitin Thiolesterase/metabolism ; Cyclins/metabolism
Czasopismo naukowe
Tytuł:
Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers.
Autorzy:
Stewart DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Cole K; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA.
Bosse D; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Brule S; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Fergusson D; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Ramsay T; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 20; Vol. 31 (3), pp. 1600-1617. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Small Cell Lung Carcinoma*
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Neoplasm Staging ; Neoplasm Recurrence, Local ; Recurrence
Czasopismo naukowe
Tytuł:
Polydopamine-Coated Liposomes for Methylene Blue Delivery in Anticancer Photodynamic Therapy: Effects in 2D and 3D Cellular Models.
Autorzy:
De Leo V; Department of Chemistry, University of Bari Aldo Moro, via Orabona 4, 70126 Bari, Italy.
Marras E; Department of Biotechnology and Life Sciences (DBSV), University of Insubria, via JH Dunant 3, 21100 Varese, Italy.
Maurelli AM; Department of Chemistry, University of Bari Aldo Moro, via Orabona 4, 70126 Bari, Italy.
Catucci L; Department of Chemistry, University of Bari Aldo Moro, via Orabona 4, 70126 Bari, Italy.
Milano F; Institute of Sciences of Food Production, Italian National Research Council (CNR-ISPA), S.P. Lecce-Monteroni, I-73100 Lecce, Italy.
Gariboldi MB; Department of Biotechnology and Life Sciences (DBSV), University of Insubria, via JH Dunant 3, 21100 Varese, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 16; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Photochemotherapy*/methods
Indoles*
Polymers*
Liposomes ; Methylene Blue/pharmacology ; Methylene Blue/chemistry ; Reactive Oxygen Species ; Photosensitizing Agents/chemistry ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
The Osteocyte with SB216763-Activated Canonical Wnt Signaling Constructs a Multifunctional 4D Intelligent Osteogenic Module.
Autorzy:
Zhang J; Laboratory of Skeletal Development and Regeneration, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Zhang Y; Laboratory of Skeletal Development and Regeneration, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Chen J; Laboratory of Skeletal Development and Regeneration, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Gong W; Laboratory of Skeletal Development and Regeneration, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Tu X; Laboratory of Skeletal Development and Regeneration, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Mar 15; Vol. 14 (3). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Osteogenesis*/physiology
Wnt Signaling Pathway*
Indoles*
Maleimides*
Osteocytes ; Bone and Bones ; Tissue Engineering/methods ; Cell Differentiation
Czasopismo naukowe
Tytuł:
A Comparison of the Efficacy of Antivenoms and Varespladib against the In Vitro Pre-Synaptic Neurotoxicity of Thai and Javanese Russell's Viper ( Daboia spp.) Venoms.
Autorzy:
Lay M; Monash Venom Group, Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Hodgson WC; Monash Venom Group, Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Pokaż więcej
Źródło:
Toxins [Toxins (Basel)] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Daboia*
Neurotoxicity Syndromes*
Acetates*
Indoles*
Keto Acids*
Humans ; Animals ; Antivenins ; Venoms ; Indonesia ; Thailand
Czasopismo naukowe
Tytuł:
Mobocertinib: Mechanism of action, clinical, and translational science.
Autorzy:
Hanley MJ; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Camidge DR; University of Colorado Cancer Center, Denver, Colorado, USA.
Fram RJ; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Gupta N; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13766.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Aniline Compounds*
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Indoles*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Pyrimidines*
Adult ; Humans ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors/adverse effects ; Translational Science, Biomedical
Czasopismo naukowe
Tytuł:
Adenovirus pneumonia mimicking osimertinib-induced pneumonitis in a patient with advanced NSCLC with EGFR mutation: A case report.
Autorzy:
Imai T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (9), pp. 749-751. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/chemically induced
Lung Neoplasms*/drug therapy
Lung Neoplasms*/chemically induced
Pneumonia, Viral*
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Protein Kinase Inhibitors/adverse effects ; Mutation ; ErbB Receptors ; Adenoviridae
Raport
Tytuł:
Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first-line therapy in two patients with lung cancer harboring EGFR mutation: Case series.
Autorzy:
Koba H; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Yoneda T; Respiratory Medicine, Komatsu Municipal Hospital, Komatsu, Japan.
Morita H; Respiratory and Allergic Medicine, Morita Hospital, Komatsu, Japan.
Kimura H; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Murase Y; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Terada N; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Tambo Y; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Horie M; Department of Molecular and Cellular Pathology, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Kasahara K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Matsumoto I; Department of Thoracic Surgery, Kanazawa University, Kanazawa, Japan.
Yano S; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 661-666. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; ErbB Receptors/metabolism ; Genomics ; Disease Progression ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies